It was indeed surprising that gba+/− mice appeared to have diminished performance on the beam walk and olfaction tests, despite never developing PD-like pathologies such as α-synuclein aggregation or dopaminergic neuron depletion [20]. This evidence concerns the gene GBA1 and Parkinson disease.